| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.32 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.26 | 0.05 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.22 | 0.1 |